Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubang is a China-based rehabilitation and medical device company focused on the design, manufacture, and commercialization of wheelchairs and related rehabilitation aids. The company traces its history to 1990 in Shanghai and markets manual wheelchairs, electric wheelchairs, nursing wheelchairs, walkers, crutches, rollators, and other intelligent rehabilitation equipment. Hubang appears to operate substantial in-house manufacturing capacity across multiple production sites in China and emphasizes quality certifications including ISO13485, CE marking, FDA registration, MHRA, and CIBG registrations. It also highlights participation in drafting Chinese national standards for manual and electric wheelchairs, indicating a strong domestic industry position. For a healthcare analyst, Hubang should be viewed primarily as a commercial-stage rehabilitation device manufacturer rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubang.